Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 6, Pages 1812
Publisher
MDPI AG
Online
2023-03-17
DOI
10.3390/cancers15061812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening
- (2022) Karena D Volesky et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- HPV prevention and control – The way forward
- (2022) Alex Vorsters et al. PREVENTIVE MEDICINE
- Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
- (2022) Ian N. Hampson Viruses-Basel
- The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology
- (2022) Wei Jiang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
- (2022) Jaimie Z Shing et al. LANCET ONCOLOGY
- Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study
- (2022) Brandon Wen Bing Chua et al. Frontiers in Public Health
- HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
- (2022) Fabio Bottari et al. Diagnostics
- Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer
- (2022) Patricia Piña-Sánchez ARCHIVES OF MEDICAL RESEARCH
- IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues
- (2022) Suzanne M. Garland et al. JOURNAL OF CLINICAL VIROLOGY
- Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
- (2022) Deependra Singh et al. Lancet Global Health
- Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?
- (2022) Ming Wu et al. Frontiers in Public Health
- Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia
- (2021) Michael L. Ganz et al. JOURNAL OF MEDICAL ECONOMICS
- 2020 List of human papillomavirus assays Suitable for primary cervical cancer screening
- (2021) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
- (2021) Lee Cheng Phua et al. VACCINE
- Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
- (2021) Ditte Møller Ejegod et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
- (2021) J. Jaime Caro et al. VALUE IN HEALTH
- Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China
- (2021) Xiang Tao et al. CANCER CYTOPATHOLOGY
- Worldwide use of HPV self-sampling for cervical cancer screening
- (2021) B. Serrano et al. PREVENTIVE MEDICINE
- Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives
- (2021) Ankica Lukic et al. Vaccines
- Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France
- (2020) Salah Ghabri et al. VALUE IN HEALTH
- Impact of HPV vaccination on cervical screening performance: a population-based cohort study
- (2020) Jiayao Lei et al. BRITISH JOURNAL OF CANCER
- Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention
- (2020) Maisa Pinheiro et al. INTERNATIONAL JOURNAL OF CANCER
- Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program
- (2020) Diede L. LOOPIK et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models
- (2020) J. Jaime Caro et al. VALUE IN HEALTH
- Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening
- (2020) Eliane Rohner et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France
- (2020) Hugo Arlegui et al. CLINICAL THERAPEUTICS
- The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
- (2020) Diling Pan et al. Risk Management and Healthcare Policy
- Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007–2018: A retrospective cohort study
- (2020) Meijuan Li et al. Journal of Infection and Public Health
- Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
- (2019) Andreas Ährlund-Richter et al. Frontiers in Cellular and Infection Microbiology
- Clinical and analytical performance of the BD Onclarity HPV Assay with SurePath screening samples from the Danish cervical screening program using the VALGENT framework
- (2019) Jesper Hansen Bonde et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
- (2018) Mark H. Stoler et al. GYNECOLOGIC ONCOLOGY
- Impact of HPV-vaccination on outcome of cervical cytology screening in Denmark - a register based cohort study
- (2018) Lise Holst Thamsborg et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings
- (2017) Eun-Hee Nah et al. Annals of Laboratory Medicine
- Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix
- (2016) Louise De Brot et al. CANCER CYTOPATHOLOGY
- Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
- (2016) S. Rachel Skinner et al. INTERNATIONAL JOURNAL OF CANCER
- VALGENT: A protocol for clinical validation of human papillomavirus assays
- (2016) Marc Arbyn et al. JOURNAL OF CLINICAL VIROLOGY
- Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics
- (2016) J. Jaime Caro PHARMACOECONOMICS
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
- (2014) Henry C Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study
- (2014) Sun Kuie Tay et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide
- (2014) Paul K. S. Chan et al. PLoS One
- Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study
- (2013) Annu Heinonen et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Follow-up Testing After Colposcopy
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia
- (2012) Swee Chong Quek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
- (2012) J. Jaime Caro et al. VALUE IN HEALTH
- Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions
- (2010) J. C. Gage et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women
- (2010) A. Pista et al. CLINICAL MICROBIOLOGY AND INFECTION
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started